1
/
of
1
Elabscience
SKU:E-CL-H1025
Human TRAIL/TNFSF10(Tumor Necrosis Factor Related Apoptosis Inducing Ligand) CLIA Kit
Human TRAIL/TNFSF10(Tumor Necrosis Factor Related Apoptosis Inducing Ligand) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human TRAIL/TNFSF10 (Tumor Necrosis Factor Related Apoptosis Inducing Ligand) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient detection of TRAIL/TNFSF10 in human samples. This advanced kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise results for researchers and clinicians alike.
The Human TRAIL/TNFSF10 CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method for quantifying TRAIL/TNFSF10 levels. By utilizing this state-of-the-art technology, the kit enables researchers to explore the intricate mechanisms underlying apoptosis induction, thereby contributing to a deeper understanding of various diseases and potential therapeutic interventions.
With its comprehensive components, the Human TRAIL/TNFSF10 CLIA Kit offers a seamless workflow, allowing for streamlined and time-efficient experimentation. The kit includes all necessary reagents, standards, and controls, meticulously optimized to ensure optimal performance and reproducibility. Additionally, the user-friendly protocol provides step-by-step instructions, enabling even novice users to achieve accurate and reliable results.
The Human TRAIL/TNFSF10 CLIA Kit boasts exceptional sensitivity, with a lower limit of detection that enables the quantification of TRAIL/TNFSF10 in samples with minimal concentrations. This heightened sensitivity, coupled with a wide dynamic range, empowers researchers to accurately measure TRAIL/TNFSF10 levels across a broad spectrum, facilitating comprehensive investigations into its role in various physiological and pathological processes.
Furthermore, the Human TRAIL/TNFSF10 CLIA Kit exhibits outstanding specificity, ensuring minimal cross-reactivity with other analytes. This specificity guarantees the precise quantification of TRAIL/TNFSF10, eliminating potential confounding factors and enabling researchers to draw accurate conclusions from their experiments.
In summary, the Human TRAIL/TNFSF10 CLIA Kit represents a state-of-the-art solution for the detection and quantification of TRAIL/TNFSF10 in human samples. With its exceptional sensitivity, specificity, and user-friendly design, this kit empowers researchers and clinicians to unravel the complexities of apoptosis induction, paving the way for advancements in disease research and therapeutic development.
The Human TRAIL/TNFSF10 CLIA Kit employs the Chemiluminescent Immunoassay (CLIA) technique, a highly sensitive and specific method for quantifying TRAIL/TNFSF10 levels. By utilizing this state-of-the-art technology, the kit enables researchers to explore the intricate mechanisms underlying apoptosis induction, thereby contributing to a deeper understanding of various diseases and potential therapeutic interventions.
With its comprehensive components, the Human TRAIL/TNFSF10 CLIA Kit offers a seamless workflow, allowing for streamlined and time-efficient experimentation. The kit includes all necessary reagents, standards, and controls, meticulously optimized to ensure optimal performance and reproducibility. Additionally, the user-friendly protocol provides step-by-step instructions, enabling even novice users to achieve accurate and reliable results.
The Human TRAIL/TNFSF10 CLIA Kit boasts exceptional sensitivity, with a lower limit of detection that enables the quantification of TRAIL/TNFSF10 in samples with minimal concentrations. This heightened sensitivity, coupled with a wide dynamic range, empowers researchers to accurately measure TRAIL/TNFSF10 levels across a broad spectrum, facilitating comprehensive investigations into its role in various physiological and pathological processes.
Furthermore, the Human TRAIL/TNFSF10 CLIA Kit exhibits outstanding specificity, ensuring minimal cross-reactivity with other analytes. This specificity guarantees the precise quantification of TRAIL/TNFSF10, eliminating potential confounding factors and enabling researchers to draw accurate conclusions from their experiments.
In summary, the Human TRAIL/TNFSF10 CLIA Kit represents a state-of-the-art solution for the detection and quantification of TRAIL/TNFSF10 in human samples. With its exceptional sensitivity, specificity, and user-friendly design, this kit empowers researchers and clinicians to unravel the complexities of apoptosis induction, paving the way for advancements in disease research and therapeutic development.
Share
